Category: Life Sciences
Global Life Sciences
-
Combination Antibody Therapy
... by 2030, growing at a CAGR of 13.9% over the analysis period 2023-2030. Breast Cancer Application, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$215.4 Billion ... Read More
-
Complex-Oxide Nanomaterials
... at a CAGR of 12.0% over the analysis period 2023-2030. Lithium Titanate, one of the segments analyzed in the report, is expected to record a 12.4% CAGR and reach US$1.8 Billion by the end of ... Read More
-
Genomics
... of 19.0% over the analysis period 2023-2030. Sequencing Technology, one of the segments analyzed in the report, is expected to record a 20.5% CAGR and reach US$106.1 Billion by the end of the analysis period. ... Read More
-
Hernia Repair Devices
... by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Hernia Mesh, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$3.8 Billion by ... Read More
-
Healthcare Provider Network Management
... reach US$10.5 Billion by 2030, growing at a CAGR of 14.2% over the analysis period 2023-2030. Services Component, one of the segments analyzed in the report, is expected to record a 11.9% CAGR and reach ... Read More
-
Hemodialysis
... of 4.6% over the analysis period 2023-2030. Hemodialysis Services, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$80.1 Billion by the end of the analysis period. ... Read More
-
Hemophilia Drugs
... at a CAGR of 5.4% over the analysis period 2023-2030. Hemophilia A Drugs, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$21.3 Billion by the end ... Read More
-
Hospital Acquired Infection Control
... reach US$35.1 Billion by 2030, growing at a CAGR of 2.2% over the analysis period 2023-2030. Protective Barrier, one of the segments analyzed in the report, is expected to record a 2.0% CAGR and reach ... Read More
-
Multi-Parameter Patient Monitoring Equipment
... to reach US$16.9 Billion by 2030, growing at a CAGR of 4.3% over the period 2023-2030. Portable Device, one of the segments analyzed in the report, is expected to record 4.6% CAGR and reach US$11.6 ... Read More
-
Multiplex Assays
... at a CAGR of 6.4% over the analysis period 2023-2030. Protein Assays, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$2.5 Billion by the end of ... Read More
-
Mycotoxin Testing
... at a CAGR of 5.9% over the analysis period 2023-2030. Spectroscopy- & Chromatography-Based Testing, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$1.6 Billion by the ... Read More
-
Neurosurgical Products
... at a CAGR of 10.0% over the analysis period 2023-2030. Embolization Products, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$8.8 Billion by the end of ... Read More
-
Nuclear Medicine Radioisotope
... by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Technetium-99m (Tc-99m), one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$11.7 Billion by ... Read More
-
Ocular Implants
... at a CAGR of 4.3% over the analysis period 2023-2030. Glaucoma Implants, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$6.5 Billion by the end of ... Read More
-
Oncology Information Systems
... by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Software Component, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$5.5 Billion by ... Read More
-
Operating Room Integrated Systems
... reach US$5.1 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2023-2030. HD Display Systems, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and ... Read More
-
Immunotherapy Drugs
... at a CAGR of 9.6% over the analysis period 2023-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$254.4 Billion by the end of ... Read More
-
Patient Handling Equipment
... by 2030, growing at a CAGR of 2.1% over the analysis period 2023-2030. Medical Beds, one of the segments analyzed in the report, is expected to record a 2.0% CAGR and reach US$6.8 Billion by ... Read More
-
Patient Throughput and Capacity Management Solutions
... the year 2023, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Real Time Locating System (RTLS), one of the segments analyzed in the report, ... Read More
-
Percutaneous Coronary Intervention (PCI) Devices
... is expected to reach US$13.8 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Coronary Stents, one of the segments analyzed in the report, is expected to record a 5.1% ... Read More
-
Arterial Stents
... at a CAGR of 8.2% over the analysis period 2023-2030. Coronary Stents, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$12.8 Billion by the end of ... Read More
-
Knee Braces
... at a CAGR of 5.1% over the analysis period 2023-2030. Functional, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$875.4 Million by the end of the ... Read More
-
Hydrogel Dressings
... at a CAGR of 7.2% over the analysis period 2023-2030. Amorphous Hydrogel, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$810.7 Million by the end of ... Read More
-
Glaucoma Surgery Devices
... by 2030, growing at a CAGR of 20.7% over the analysis period 2023-2030. Traditional Surgery Method, one of the segments analyzed in the report, is expected to record a 20.5% CAGR and reach US$3.1 Billion ... Read More
-
Implantable Ports
... at a CAGR of 3.1% over the analysis period 2023-2030. Single-Lumen Implantable Ports, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$186.6 Million by the end ... Read More
Research Assistance
